COOKSON PEIRCE & CO INC

Position in GILD — Gilead Sciences, Inc.

CIK 1141455 PITTSBURGH, PA

Position in GILD

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$1,134,154

-$73,208 QoQ

Shares Held

8,977

+3.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#1,014

of 2,266 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

COOKSON PEIRCE & CO INC holds $68,000,592 across 6 Drug Manufacturers - General names. GILD ranks #4 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG	283,840	$44,483,404
2	LLY	ELI LILLY & Co	16,449	$19,729,425
3	AZN	Astrazeneca PLC	9,055	$1,717,009
4	GILD	Gilead Sciences, Inc. This page	8,977	$1,134,154
5	BMY	Bristol Myers Squibb Co	9,943	$572,915
6	JNJ	Johnson & Johnson	1,432	$363,685

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,134,154	8,977	+3.6%	Shares	Sole	2026-07-23
2026-03-31	$1,207,362	8,663	-23.2%	Shares	Sole	2026-04-30
2025-12-31	$1,383,893	11,275	+12.2%	Shares	Sole	2026-02-11
2025-09-30	$1,114,995	10,045	+249.1%	Shares	Sole	2025-11-06
2025-06-30	$318,972	2,877	—	Shares	Sole	2025-07-30
No filing history on record for this holder in this stock.